Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Moon Fenton"'
Autor:
Steven Borson, Yongli Shuai, Barton F. Branstetter, Marci Lee Nilsen, Marion A. Hughes, Moon Fenton, Mark Kubik, Shaum Sridharan, David A. Clump, Heath D. Skinner, Jonas T. Johnson, Simion I. Chiosea, James Ohr, Umamaheswar Duvvuri, Seungwon Kim, Katie S. Traylor, Robert Ferris, Dan P. Zandberg
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 7, Iss 3, Pp 757-765 (2022)
Abstract Objectives Data on the efficacy of including definitive local therapy to the primary site for head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking. In multiple different solid tumor types, th
Externí odkaz:
https://doaj.org/article/8e063f3a91944f3ebecff1d2f616b066
Publikováno v:
Case Reports in Surgery, Vol 2015 (2015)
Primary squamous cell carcinoma (SCC) of the gallbladder is a rare malignancy of the gallbladder, accounting for less than 5% of gallbladder pathology. Initial presentation is often similar to adenocarcinoma of the gallbladder. SCC tends to be more l
Externí odkaz:
https://doaj.org/article/6fce513eba8e48f49183a0fe8b78fcdf
Autor:
Marco Antonio Mascarella, Tolani Olonisakin, Purva Rumde, Varun Vendra, Melonie Nance, Seungwon Kim, Mark Kubik, Shaum Sridharan, Robert Ferris, Moon Fenton, Daniel Clayburgh, James Ohr, Malabika Sen, Sonali Joyce, James Herman, Jennifer Grandis, Dan Zandberg, Umamaheswar Duvvuri
Publikováno v:
Cancer Research. 83:4338-4338
Purpose: Neoadjuvant targeted therapy provides a brief, preoperative ‘window of opportunity’ that can be exploited to individualize cancer care based on treatment response. We investigated whether response to neoadjuvant therapy during the preope
Publikováno v:
Clinical Genitourinary Cancer. 16:e1171-e1179
Current real-world data regarding treatment patterns in advanced bladder cancer in the community setting are limited. This study describes patient characteristics, treatment patterns, and effectiveness outcomes for stage IV bladder cancer in the comm
Autor:
Cristina P. Rodriguez, Gregory S. Weinstein, Matthew E. Witek, Moon Fenton, Loren K. Mell, Robert I. Haddad, Randal S. Weber, Jimmy J. Caudell, Debra S. Leizman, Harlan A. Pinto, Yoshimi Anzai, David G. Pfister, Jennifer L. Burns, Ying J. Hitchcock, John A. Ridge, James W. Rocco, Jatin P. Shah, Ellie Maghami, David W. Eisele, Wesley L. Hicks, Douglas Adkins, Thomas J. Galloway, A. Dimitrios Colevas, Susan Darlow, Bharat B. Mittal, Maura L. Gillison, Weining Zhen, Paul M. Busse, David M. Brizel, Justine Yang Bruce, Sue S. Yom, Anthony J. Cmelak, David J. Adelstein, Frank Worden, Robert L. Foote, Antonio Jimeno, Sharon A. Spencer
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 18(7)
Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This
Autor:
Moon Fenton, Temitope Olufade, Maxine D. Fisher, Ancilla W. Fernandes, Mark S. Walker, Paul J. E. Miller
Publikováno v:
Clinical Therapeutics. 40:1522-1537
Purpose The purpose of this study was to provide an understanding of the effectiveness of existing therapies in patients with advanced head and neck cancer (HNC), particularly in clinical practice. Methods Data from the electronic medical records of
Autor:
David G. Pfister, Anthony J. Cmelak, Douglas Adkins, Sue S. Yom, John A. Ridge, Harlan A. Pinto, James W. Rocco, Moon Fenton, David W. Eisele, David M. Brizel, Jatin P. Shah, Loren K. Mell, Weining Zhen, Robert I. Haddad, Maura L. Gillison, Cristina P. Rodriguez, William M. Lydiatt, Jill Gilbert, Wesley L. Hicks, Jennifer L. Burns, A. Dimitrios Colevas, Barbara Burtness, Bharat B. Mittal, Ying J. Hitchcock, Randal S. Weber, Antonio Jimeno, David J. Adelstein, Paul M. Busse, Sharon A. Spencer, Jimmy J. Caudell, Debra S. Leizman, Ellie Maghami, Susan Darlow, Matthew E. Witek, Frank Worden, Robert L. Foote
Publikováno v:
Adelstein, David; Gillison, Maura L; Pfister, David G; Spencer, Sharon; Adkins, Douglas; Brizel, David M; et al.(2017). NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.. Journal of the National Comprehensive Cancer Network : JNCCN, 15(6), 761-770. doi: 10.6004/jnccn.2017.0101. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/8bd6h33b
Journal of the National Comprehensive Cancer Network : JNCCN, vol 15, iss 6
Journal of the National Comprehensive Cancer Network : JNCCN, vol 15, iss 6
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations
Autor:
Robert L. Ferris, James Ohr, Varun Vendra, Moon Fenton, Shaum Sridharan, Marco Antonio Mascarella, Mark Kubik, Seungwon Kim, Umamaheswar Duvvuri, Dan P. Zandberg
Publikováno v:
Journal of Clinical Oncology. 39:6033-6033
6033 Background: Quality oncologic care, including negative surgical margin status, adequate lymph node yield and prompt initiation of adjuvant treatment, impacts disease control and overall survival in patients with mucosal head and neck squamous ce
Autor:
James Ohr, Jonas T. Johnson, Steven Borson, Shaum Sridharan, Yongli Shuai, Katie S. Traylor, Mark Kubik, Umamaheswar Duvvuri, Moon Fenton, Heath D. Skinner, Seungwon Kim, Robert L. Ferris, Simion I. Chiosea, David A. Clump, Barton F. Branstetter, Dan P. Zandberg, Marci Lee Nilsen, Marion A. Hughes
Publikováno v:
Journal of Clinical Oncology. 39:e18014-e18014
e18014 Background: Data on the efficacy of including definitive local therapy to the primary head and neck disease (PHN) for non-nasopharyngeal head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking. Me
Autor:
Krzysztof Misiukiewicz, Ammar Sukari, Prakash Neupane, Gregory N. Dietsch, Assuntina G. Sacco, M. K. Gibson, Barbara J. Gitlitz, Charles J. Schneider, Robert M. Hershberg, Raphael Gottardo, Moon Fenton, Douglas Adkins, Kristi Manjarrez, Keisuke Shirai, John C. Morris, Ezra E.W. Cohen, James Kyle Bryan, Daniel W. Bowles, Robert I. Haddad, Antonio Jimeno, Robert L. Ferris, Nabil F. Saba, Julie E. Bauman, Tobenna Nwizu
Importance Immunotherapy for recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) is promising. The toll-like receptor 8 (TLR8) agonist motolimod may stimulate innate and adaptive immunity. Objective To determine whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ab8b8a343cdbd6c5cfe17d54a12863
https://europepmc.org/articles/PMC6248084/
https://europepmc.org/articles/PMC6248084/